These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Four cases of severe hepatotoxicity associated with pemoline: possible autoimmune pathogenesis. Rosh JR; Dellert SF; Narkewicz M; Birnbaum A; Whitington G Pediatrics; 1998 May; 101(5):921-3. PubMed ID: 9565425 [No Abstract] [Full Text] [Related]
4. Pemoline and hepatotoxicity. McCurry L; Cronquist S Am J Psychiatry; 1997 May; 154(5):713-4. PubMed ID: 9137138 [No Abstract] [Full Text] [Related]
5. Pemoline hepatotoxicity in children. Marotta PJ; Roberts EA J Pediatr; 1998 May; 132(5):894-7. PubMed ID: 9602211 [TBL] [Abstract][Full Text] [Related]
6. Pemoline-associated fulminant liver failure: testing the evidence for causation. Berkovitch M; Pope E; Phillips J; Koren G Clin Pharmacol Ther; 1995 Jun; 57(6):696-8. PubMed ID: 7781270 [TBL] [Abstract][Full Text] [Related]
8. Pemoline therapy resulting in liver transplantation. Adcock KG; MacElroy DE; Wolford ET; Farrington EA Ann Pharmacother; 1998 Apr; 32(4):422-5. PubMed ID: 9562136 [TBL] [Abstract][Full Text] [Related]
9. Pemoline (Cylert) for minimal brain dysfunction. Med Lett Drugs Ther; 1976 Jan; 18(2):5-6. PubMed ID: 1107790 [No Abstract] [Full Text] [Related]
10. Evidence of lack of abuse or dependence following pemoline treatment: results of a retrospective survey. Langer DH; Sweeney KP; Bartenbach DE; Davis PM; Menander KB Drug Alcohol Depend; 1986 Jun; 17(2-3):213-27. PubMed ID: 3743405 [TBL] [Abstract][Full Text] [Related]
11. Effect on growth in pemoline-treated children with attention deficit disorder. Friedmann N; Thomas J; Carr R; Elders J; Ringdahl I; Roche A Am J Dis Child; 1981 Apr; 135(4):329-32. PubMed ID: 7211792 [TBL] [Abstract][Full Text] [Related]
12. Pemoline-associated hepatic failure: a critical analysis of the literature. Shevell M; Schreiber R Pediatr Neurol; 1997 Jan; 16(1):14-6. PubMed ID: 9044395 [TBL] [Abstract][Full Text] [Related]
13. Hepatotoxicity due to pemoline. Report of two cases. Tolman KG; Freston JW; Berenson MM; Sannella JJ Digestion; 1973; 9(6):532-9. PubMed ID: 4787851 [TBL] [Abstract][Full Text] [Related]
15. Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction. Conners CK; Taylor E Arch Gen Psychiatry; 1980 Aug; 37(8):922-30. PubMed ID: 7406656 [TBL] [Abstract][Full Text] [Related]
17. Pemoline-induced Tourette's disorder: a case report. Bachman DS Am J Psychiatry; 1981 Aug; 138(8):1116-7. PubMed ID: 6942661 [TBL] [Abstract][Full Text] [Related]
18. Pemoline pharmacokinetics and long term therapy in children with attention deficit disorder and hyperactivity. Collier CP; Soldin SJ; Swanson JM; MacLeod SM; Weinberg F; Rochefort JG Clin Pharmacokinet; 1985; 10(3):269-78. PubMed ID: 4017397 [TBL] [Abstract][Full Text] [Related]
19. Change from Mg-pemoline to bupropion in a 12-year-old boy with attention-deficit hyperactivity disorder. Bloomingdale LM J Clin Psychopharmacol; 1990 Oct; 10(5):382-3. PubMed ID: 2124222 [No Abstract] [Full Text] [Related]